.png)
A Future Built on Genetic Precision
There are over 7,000 known inherited rare genetic diseases, yet fewer than 5% have FDA-approved treatments. For many families, meaningful therapeutic options simply do not exist.
At Origin Genomics, we are developing next-generation gene correction technologies designed to address serious inherited diseases at their source.
Our work is focused on advancing scientifically rigorous, ethically responsible approaches to gene editing, with the long-term goal of preventing or correcting disease-causing mutations once therapies are proven safe, effective, and fully approved by regulatory authorities.
We understand that for many families facing genetic conditions, time matters. We also believe that safety, transparency, and scientific integrity matter just as much.
Interested in future Gene Therapies?
If you or your family are affected by a serious genetic condition and would like to stay informed about future developments, you may register your interest below. By joining our contact list, you will:
If you or your family are affected by a serious genetic condition and would like to stay informed about future developments, you may register your interest below. By joining our contact list, you will:
Submitting your information does not constitute enrollment in a clinical trial, medical advice, or guaranteed access to treatment.
All therapies would only be offered following appropriate regulatory authorization and ethical oversight.
Our commitment to patients
We do not offer unapproved treatments.
We do not provide experimental interventions outside proper regulatory pathways.
We prioritize safety, transparency, and independent oversight.
We are committed to working within U.S. and international regulatory frameworks.
Stay connected
If you would like to be informed about future approved gene therapies, please complete the form below.
We cannot provide individual medical guidance at this time. For medical decisions, please consult your physician or a licensed genetic specialist.
